title: Focal nodular hyperplasia after busulfan treatment.
abstract: The case of a 48-year-old woman in whom focal nodular hyperplasia of the liver developed after busulfan therapy was administered for essential thrombocytosis is described. Focal nodular hyperplasia is a reactive disorder related to a circulation disorder. The close temporal relation between the haematological disease, busulfan treatment and the appearance of hyperplastic diseases of the liver in our patient supports the possibility that the association of the events might not be casual.
authors.affiliation: Department of Internal Medicine, Faenza Hospital, Via Stradone no. 9, 48018 Faenza (RA), Italy. fgfoschi@tin.it
authors.forename: F G
authors.initials: FG
authors.lastname: Foschi
authors.forename: P
authors.initials: P
authors.lastname: Savini
authors.forename: G
authors.initials: G
authors.lastname: Marano
authors.forename: G
authors.initials: G
authors.lastname: Musardo
authors.forename: E
authors.initials: E
authors.lastname: Bedeschi
authors.forename: F
authors.initials: F
authors.lastname: Girelli
authors.forename: F
authors.initials: F
authors.lastname: Emiliani
authors.forename: M
authors.initials: M
authors.lastname: Aldi
authors.forename: A
authors.initials: A
authors.lastname: D'Errico
authors.forename: M
authors.initials: M
authors.lastname: Bernardi
authors.forename: G F
authors.initials: GF
authors.lastname: Stefanini
mesh_terms: D002066:Busulfan / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D020518:Focal Nodular Hyperplasia / Q000139:chemically induced* / Q000000981:diagnostic imaging; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D008875:Middle Aged; D013922:Thrombocytosis / Q000188:drug therapy; D014463:Ultrasonography
chemical_list: D007166:Immunosuppressive Agents; D002066:Busulfan